
A woman who has received a breakthrough gene-editing treatment on the NHS is hoping 2026 is the year she will be cured of a major blood disorder.
Kavita Mehta, 36, from London, has beta thalassaemia, which means her body fails to produce enough haemoglobin – the protein in red blood cells that carries oxygen around the body.